ELTD1, a Potential New Biomarker for Gliomas-Reference-Cited by-同舟云学术

ELTD1, a Potential New Biomarker for Gliomas

Published:2013-01 Issue:1 Volume:72 Page:77-91
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:Neurosurgery

Author:

Towner Rheal A.,Jensen Randy L.,Colman Howard,Vaillant Brian,Smith Nataliya,Casteel Rebba,Saunders Debra,Gillespie David L.,Silasi-Mansat Robert,Lupu Florea,Giles Cory B.,Wren Jonathan D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/72/1/77/13952736/neurosurgery-72-1-77.pdf

Reference51 articles.

1. MOLECULAR PATHOLOGY OF MALIGNANT GLIOMAS

2. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

3. Molecular diagnostics of gliomas: state of the art

4. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy: creating opportunities in brain space;British Journal of Cancer;2023-09-26

2. In vitro evaluation of Axitinib and Sorafenib treatment in glioblastoma cell viability and morphology;Romanian Journal of Morphology and Embryology;2023-07-28

3. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas;International Immunopharmacology;2023-04

4. Targeting Bioinformatics Predicted Biomarkers Associated with Cell Proliferation and Migration for Treating Gliomas: Preclinical Studies in a GL261 Mouse Model;Neuroglia;2023-03-15

5. Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology;Physiological Reviews;2022-10-01